About Diabeloop
Diabeloop is a company based in Grenoble (France) founded in 2015 by Erik Huneker.. Diabeloop has raised $124.31 million across 5 funding rounds from investors including Air Liquide, Bpifrance and Terumo Medical. Diabeloop offers products and services including DBLG1 and YourLoops. Diabeloop operates in a competitive market with competitors including Livongo, One Drop, Insulet, Bigfoot Biomedical and mySugr, among others.
- Headquarter Grenoble, France
- Founders Erik Huneker
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Diabeloop
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$124.31 M (USD)
in 5 rounds
-
Latest Funding Round
$74.83 M (USD), Series C
Jun 02, 2022
-
Investors
Air Liquide
& 11 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Diabeloop
Diabeloop offers a comprehensive portfolio of products and services, including DBLG1 and YourLoops. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Automates insulin delivery for type 1 diabetes patients.
Enables visualization and management of diabetes health data.
Unlock access to complete
Funding Insights of Diabeloop
Diabeloop has successfully raised a total of $124.31M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $74.83 million completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series C — $74.8M
-
First Round
First Round
(01 Jul 2017)
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2022 | Amount | Series C - Diabeloop | Valuation | LBO France | |
| Mar, 2021 | Amount | Grant - Diabeloop | Valuation |
investors |
|
| Dec, 2019 | Amount | Series B - Diabeloop | Valuation | Odyssee Venture |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Diabeloop
Diabeloop has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Air Liquide, Bpifrance and Terumo Medical. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are made in France and the US.
|
Founded Year | Domain | Location | |
|
Investments are directed toward early-stage technology-led companies by Innovacom.
|
Founded Year | Domain | Location | |
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Diabeloop
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Diabeloop
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Diabeloop Comparisons
Competitors of Diabeloop
Diabeloop operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Livongo, One Drop, Insulet, Bigfoot Biomedical and mySugr, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of smart devices for diabetes management for patients and doctors
|
|
| domain | founded_year | HQ Location |
Provider of workforce healthcare solutions
|
|
| domain | founded_year | HQ Location |
Wearable insulin infusion systems are developed for diabetes patients.
|
|
| domain | founded_year | HQ Location |
Developer of a closed-loop automated insulin delivery system
|
|
| domain | founded_year | HQ Location |
Gamified apps for diabetes management and therapy are provided.
|
|
| domain | founded_year | HQ Location |
Implantable continuous glucose monitoring systems are provided for diabetes management.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Diabeloop
Frequently Asked Questions about Diabeloop
When was Diabeloop founded?
Diabeloop was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Where is Diabeloop located?
Diabeloop is headquartered in Grenoble, France. It is registered at Grenoble, Auvergne-rhone-alpes, France.
Who is the current CEO of Diabeloop?
Marc Julien is the current CEO of Diabeloop.
Is Diabeloop a funded company?
Diabeloop is a funded company, having raised a total of $124.31M across 5 funding rounds to date. The company's 1st funding round was a Series B of $34.22M, raised on Jul 01, 2017.
What does Diabeloop do?
Diabeloop was founded in 2015 in Grenoble, France, within the health technology sector. An AI-driven system is provided for managing type 1 diabetes in adults, featuring the DBLG1 as a user interface linked to a continuous glucose sensor and insulin pump. Glucose data is transmitted periodically to the DBLG1, where results are analyzed to determine precise insulin doses for administration. Operations focus on automated diabetes care solutions.
Who are the top competitors of Diabeloop?
Diabeloop's top competitors include Insulet, Senseonics and Bigfoot Biomedical.
What products or services does Diabeloop offer?
Diabeloop offers DBLG1 and YourLoops.
Who are Diabeloop's investors?
Diabeloop has 12 investors. Key investors include Air Liquide, Bpifrance, Terumo Medical, European Union, and LBO France.